View ValuationNeurones 将来の成長Future 基準チェック /26Neurones利益と収益がそれぞれ年間9.5%と4.9%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に14.4% 9.4%なると予測されています。主要情報9.5%収益成長率9.39%EPS成長率IT 収益成長14.2%収益成長率4.9%将来の株主資本利益率14.41%アナリストカバレッジLow最終更新日07 May 2026今後の成長に関する最新情報お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.すべての更新を表示Recent updatesDeclared Dividend • May 04Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Apr 28Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €35.45. The fair value is estimated to be €45.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre FranceBuy Or Sell Opportunity • Apr 13Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €35.70. The fair value is estimated to be €45.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.Reported Earnings • Mar 13Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the IT industry in the United Kingdom.お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026Buy Or Sell Opportunity • Sep 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €39.20. The fair value is estimated to be €49.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Reported Earnings • Sep 13First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the IT industry in the United Kingdom.Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.1%).Board Change • May 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre FranceBuy Or Sell Opportunity • Apr 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to €45.70. The fair value is estimated to be €37.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.お知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025Buy Or Sell Opportunity • Aug 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.85. The fair value is estimated to be €51.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (2.3%).お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.Buy Or Sell Opportunity • Apr 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €48.00. The fair value is estimated to be €39.38, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Buy Or Sell Opportunity • Mar 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 5.2% to €45.95. The fair value is estimated to be €38.16, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Reported Earnings • Mar 07Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.Buy Or Sell Opportunity • Mar 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to €45.90. The fair value is estimated to be €38.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 4.3% in a year. Earnings are forecast to grow by 4.2% in the next year.お知らせ • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.Buying Opportunity • Oct 31Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.9%. The fair value is estimated to be €42.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Buying Opportunity • Oct 09Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.8%. The fair value is estimated to be €45.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the IT industry in the United Kingdom.お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.5%).お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.Reported Earnings • Mar 11Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 14% growth forecast for the IT industry in the United Kingdom.お知らせ • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.お知らせ • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the IT industry in the United Kingdom.Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (4.8%). Higher than average of industry peers (2.4%).Reported Earnings • Apr 27Full year 2021 earnings releasedFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 8.3%, compared to a 16% growth forecast for the industry in the United Kingdom.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 18% growth forecast for the industry in the United Kingdom.Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (2.0%).Reported Earnings • May 03Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 9.7% growth forecast for the IT industry in the United Kingdom.業績と収益の成長予測LSE:0GX2 - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202899269N/AN/A112/31/202795063N/AN/A112/31/202690457N/AN/A112/31/2025857526171N/A9/30/2025845516475N/A6/30/2025832516678N/A3/31/2025821526981N/A12/31/2024810537284N/A9/30/2024793515873N/A6/30/2024775484362N/A3/31/2024758494967N/A12/31/2023741495472N/A9/30/2023724495974N/A6/30/2023707486476N/A3/31/2023686465465N/A12/31/2022665444455N/A9/30/2022642434251N/A6/30/2022618414047N/A3/31/2022599404956N/A12/31/2021580385864N/A9/30/2021570375865N/A6/30/2021559365866N/A3/31/2021542335967N/A12/31/2020524316067N/A9/30/2020518306169N/A6/30/2020511286370N/A3/31/2020510305866N/A12/31/2019510315361N/A9/30/201950530N/A53N/A6/30/201950130N/A45N/A3/31/201949528N/A38N/A12/31/201849026N/A31N/A9/30/201848726N/A28N/A6/30/201848326N/A25N/A3/31/201848427N/A24N/A12/31/201748527N/A23N/A9/30/201747827N/A24N/A6/30/201747027N/A25N/A3/31/201745926N/A23N/A12/31/201644725N/A21N/A9/30/201643624N/A21N/A6/30/201642523N/A20N/A3/31/201641222N/A25N/A12/31/201539921N/A30N/A9/30/201538621N/A30N/A6/30/201537421N/A29N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0GX2の予測収益成長率 (年間9.5% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 0GX2の収益 ( 9.5% ) UK市場 ( 11.5% ) よりも低い成長が予測されています。高成長収益: 0GX2の収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 0GX2の収益 ( 4.9% ) UK市場 ( 4.5% ) よりも速いペースで成長すると予測されています。高い収益成長: 0GX2の収益 ( 4.9% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0GX2の 自己資本利益率 は、3年後には低くなると予測されています ( 14.4 %)。成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 13:05終値2026/05/20 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neurones S.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Alexandre PlaudCIC Market Solutions (ESN)
お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.
お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.
お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.
Declared Dividend • May 04Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Apr 28Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €35.45. The fair value is estimated to be €45.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.
お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France
Buy Or Sell Opportunity • Apr 13Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €35.70. The fair value is estimated to be €45.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.4% per annum. Earnings are also forecast to grow by 10% per annum over the same time period.
Reported Earnings • Mar 13Full year 2025 earnings releasedFull year 2025 results: Revenue: €857.2m (up 5.8% from FY 2024). Net income: €52.1m (flat on FY 2024). Profit margin: 6.1% (down from 6.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the IT industry in the United Kingdom.
お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
Buy Or Sell Opportunity • Sep 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to €39.20. The fair value is estimated to be €49.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. For the next 3 years, revenue is forecast to grow by 5.3% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Reported Earnings • Sep 13First half 2025 earnings releasedFirst half 2025 results: Revenue: €424.3m (up 5.4% from 1H 2024). Net income: €22.7m (down 7.3% from 1H 2024). Profit margin: 5.3% (down from 6.1% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the IT industry in the United Kingdom.
Upcoming Dividend • Jun 04Upcoming dividend of €1.30 per shareEligible shareholders must have bought the stock before 11 June 2025. Payment date: 13 June 2025. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.1%).
Board Change • May 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France
Buy Or Sell Opportunity • Apr 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 3.2% to €45.70. The fair value is estimated to be €37.65, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
Reported Earnings • Mar 09Full year 2024 earnings releasedFull year 2024 results: Revenue: €810.4m (up 9.3% from FY 2023). Net income: €52.5m (up 6.3% from FY 2023). Profit margin: 6.5% (down from 6.7% in FY 2023). The decrease in margin was driven by higher expenses.
お知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).
お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025
Buy Or Sell Opportunity • Aug 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 11% to €40.85. The fair value is estimated to be €51.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 8.0% in a year. Earnings are forecast to grow by 2.2% in the next year.
Upcoming Dividend • Jun 05Upcoming dividend of €1.20 per shareEligible shareholders must have bought the stock before 12 June 2024. Payment date: 14 June 2024. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (2.3%).
お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
Declared Dividend • May 03Dividend of €1.20 announcedShareholders will receive a dividend of €1.20. Ex-date: 12th June 2024 Payment date: 14th June 2024 Dividend yield will be 2.7%, which is higher than the industry average of 2.4%. Sustainability & Growth The dividend has increased by an average of 35% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to remain steady over the next year, which should provide adequate earnings cover for the dividend.
Buy Or Sell Opportunity • Apr 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to €48.00. The fair value is estimated to be €39.38, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Buy Or Sell Opportunity • Mar 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 5.2% to €45.95. The fair value is estimated to be €38.16, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Reported Earnings • Mar 07Full year 2023 earnings releasedFull year 2023 results: Revenue: €741.2m (up 11% from FY 2022). Net income: €49.4m (up 12% from FY 2022). Profit margin: 6.7% (up from 6.6% in FY 2022). The increase in margin was driven by higher revenue.
Buy Or Sell Opportunity • Mar 07Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 16% to €45.90. The fair value is estimated to be €38.23, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 4.3% in a year. Earnings are forecast to grow by 4.2% in the next year.
お知らせ • Nov 28+ 2 more updatesNeurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024Neurones S.A. announced that they will report fiscal year 2023 results on Mar 06, 2024
お知らせ • Nov 10Neurones S.A. Provides Earnings Guidance for the Year 2023Neurones S.A. provided earnings guidance for the year 2023. The company confirms its forecasts for 2023 as a whole: revenues of more than €730 million, operating profit of around 10%.
Buying Opportunity • Oct 31Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 9.9%. The fair value is estimated to be €42.98, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Buying Opportunity • Oct 09Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.8%. The fair value is estimated to be €45.84, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Reported Earnings • Sep 08First half 2023 earnings releasedFirst half 2023 results: Revenue: €368.7m (up 13% from 1H 2022). Net income: €25.4m (up 15% from 1H 2022). Profit margin: 6.9% (up from 6.7% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the IT industry in the United Kingdom.
お知らせ • Sep 07Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of more than €730 million and operating profit of around 10%.
Upcoming Dividend • Jun 07Upcoming dividend of €1.10 per share at 2.8% yieldEligible shareholders must have bought the stock before 14 June 2023. Payment date: 16 June 2023. Payout ratio is a comfortable 60% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.5%).
お知らせ • May 11Neurones S.A. Provides Earnings Guidance for the Full Year 2023Neurones S.A. provided earnings guidance for the full year 2023. For the year, the company expects revenue of €730 million and operating profit of around 10%.
Reported Earnings • Mar 11Full year 2022 earnings releasedFull year 2022 results: Revenue: €665.4m (up 15% from FY 2021). Net income: €44.3m (up 18% from FY 2021). Profit margin: 6.7% (up from 6.5% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 14% growth forecast for the IT industry in the United Kingdom.
お知らせ • Feb 09Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023Neurones S.A. announced that they will report fiscal year 2022 results After-Market on Mar 08, 2023
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 12Neurones S.A., Annual General Meeting, Jun 08, 2023Neurones S.A., Annual General Meeting, Jun 08, 2023.
お知らせ • Nov 11Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023Neurones S.A. announced that they will report first half, 2023 results on Sep 06, 2023
Reported Earnings • Sep 09First half 2022 earnings releasedFirst half 2022 results: Revenue: €327.1m (up 13% from 1H 2021). Net income: €22.1m (up 21% from 1H 2021). Profit margin: 6.8% (up from 6.3% in 1H 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 16% growth forecast for the IT industry in the United Kingdom.
Upcoming Dividend • Jun 01Upcoming dividend of €1.00 per shareEligible shareholders must have bought the stock before 08 June 2022. Payment date: 10 June 2022. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (4.8%). Higher than average of industry peers (2.4%).
Reported Earnings • Apr 27Full year 2021 earnings releasedFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 8.3%, compared to a 16% growth forecast for the industry in the United Kingdom.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 11Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €579.9m (up 11% from FY 2020). Net income: €37.7m (up 22% from FY 2020). Profit margin: 6.5% (up from 5.9% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 8.3%, compared to a 18% growth forecast for the industry in the United Kingdom.
Upcoming Dividend • Jun 02Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 09 June 2021. Payment date: 11 June 2021. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (2.0%).
Reported Earnings • May 03Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)The company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.
Reported Earnings • Mar 06Full year 2020 earnings releasedThe company reported a mediocre full year result with weaker profit margins, although earnings were flat and revenues improved. Full year 2020 results: Revenue: €524.5m (up 2.8% from FY 2019). Net income: €30.9m (flat on FY 2019). Profit margin: 5.9% (down from 6.0% in FY 2019). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Mar 06Revenue beats expectationsRevenue exceeded analyst estimates by 1.2%. Over the next year, revenue is forecast to grow 5.0%, compared to a 9.7% growth forecast for the IT industry in the United Kingdom.